搜索临床试验以:Somatic BRCA1/2 mutations
总计49238个结果
-
PfizerMedivation, Inc.完全的
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
Catholic University of the Sacred Heart未知
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
NYU Langone Health撤销乳腺癌 | BRCA1突变 | BRCA2突变美国
-
University of Alabama at BirminghamNational Cancer Institute (NCI)撤销卵巢癌 | brca1突变携带者 | brca2突变携带者美国
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)未知乳腺癌 | brca1突变携带者 | brca2突变携带者美国
-
Centre Hospitalier Universitaire de Besancon完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)撤销
-
Royal Marsden NHS Foundation Trust完全的
-
Weill Medical College of Cornell University完全的
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology完全的
-
Fundació Institut de Recerca de l'Hospital de la...招聘中
-
Melinda TelliPfizer; BioMarin Pharmaceutical完全的
-
University College London Hospitals完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2) | brca1突变携带者 | brca2突变携带者澳大利亚, 以色列, 英国, 西班牙, 瑞典, 葡萄牙
-
Indiana UniversityBreast Cancer Research Foundation撤销
-
Health DecisionsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)完全的
-
Spanish Breast Cancer Research GroupAstraZeneca完全的